Vivaglobin sales are going quite well. Most of REPR's sales for the Freedom60 are for Vivaglobin use. Here is what CSL, the maker of Vivaglobin, stated about Vivaglobin sales:
Immunoglobulins grew 26% in US dollar terms with Carimune® / Sandoglobulin® (Intravenous Immunoglobulin), Vivaglobin® (subcutaneous Immunoglobulin) and Rhophylac® (used in the prevention of haemolytic disease of the new born) performing particularly well. Vivaglobin®, which provides patients with the convenience of self administration of immunoglobulin, attracted significant new patient demand.
Market Data 
Markets 
AI
